Would you be interested in launching the first leave-on foam product treating Seborrheic Dermatitis and Tinea Versicolor in Europe?

Formula
Proderm Technology Foam formulation with 2.25% Seleniumsulfide.

Local treatment
The general trend is that sales of topical treatments increases and systemic treatments decreases. Offering a topical foam treating Dermatitis is in alignment with such trend.

Prevalence
2-8% of the population (U.S.) is affected by Tinea Versicolor

Added Benefit
Great opportunity for a non-greasy foam based on Proderm Technology treating Tinea Versiocolor and that adds the Proderm generic benefits: Protect - Hydrate - Repair.

Quality of Life
Tinea Versicolor has a big impact on the quality of life. This is a problem description from a patient that can be found on medicinenet.com:

"When I discovered tinea versicolor was growing on my skin, it was very uncomfortable. I experienced itching and the area was constantly growing larger. Once it was diagnosed, the emergency room nurse told me to buy Selsun Blue shampoo and apply it to the areas every day to make it go away. I started to apply the shampoo and it burned badly. As it begin to heal, my skin looked like someone burned me with some type of hot oil and afterward, it began to peel. After the peeling, it left the areas lighter than the rest of the skin. As it was healing, the skin became extremely dry and I had to use a menthol lotion to soothe it. It grew under my breast, on my back, and the back of my neck. It was embarrassing when it started to peel, and I had to explain to people what happened, but eventually it left. I had to treat it three or four times, every other summer."

Patent protection
Proderm Technology comes with a patent protection.

Enhanced Patient Compliance
Water-based formula – low irritancy profile
Non-comedogenic – Allows the skin to maintain its natural function
Smooth penetration – No sticky residue and no staining of clothing
Great spread ability – Cover large body areas quickly
Pressurized container - Easy application and excellent antimicrobial properties

© 2011 Ponsus Pharma AB
Design by Kall3 Produktion

-a A+